I-Mab Biopharma
IMAB
#9469
Rank
C$78.79 M
Marketcap
$0.97
Share price
-6.87%
Change (1 day)
-61.13%
Change (1 year)

I-Mab Biopharma (IMAB) - Cash on Hand

Cash on Hand as of September 2024 : C$0.26 Billion

According to I-Mab Biopharma's latest financial reports the company has C$0.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

I-Mab Biopharma - Cash on Hand chart (from 2024 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$60.47 M-38.52%
2022-12-31C$98.36 M-26.7%
2021-12-31C$0.13 B-6.38%
2020-12-31C$0.14 B358.7%
2019-12-31C$31.24 M-41.15%
2018-12-31C$53.1 M212.45%
2017-12-31C$16.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$23.3 M-91.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.61 B 134.25%๐Ÿ‡บ๐Ÿ‡ธ USA